Pyrogen Testing Market To Experience Lucrative Growth Due To Increasing Demand For Therapeutic Drugs Till 2025: Grand View Research, Inc.
The
global pyrogen testing market is expected to reach a
value of USD 1.9 billion by 2025, according to a new report by Grand View
Research, Inc. Increasing demand for therapeutic drugs including
pharmaceuticals, biopharmaceuticals, and biologics is the major factor that
propels growth of the market during forecast period. Pyrogen is a toxic
molecular substance that causes fever if induced in animal or human body.
Pyrogen testing is used by pharmaceutical, biopharmaceuticals, biotechnology,
and medical devices companies to confirm the absence of pyrogen. Thus, the
companies use various methods such as LAL, in vitro pyrogen, and rabbit test to
ensure the quality of products.
Increasing
prevalence of chronic diseases, is another foremost factor supporting the
growth of the pyrogen testing market. The prevalence of chronic diseases is
very high in developed countries and is growing at high pace in developing
countries including China and India. Different factors such as unhealthy diet,
smoking, alcohol consumption, and lack of exercise leads to occurrence of
chronic diseases such as cancer, cardiovascular diseases, diabetes, and chronic
respiratory diseases. Hence, there is a growing demand for therapeutic
drugs and medical devices for the treatment of such diseases, which in turn is
projected to fuel the demand for pyrogen testing to ensure the quality of
products including drugs and devices.
U.S.
pyrogen testing market, by product, 2014 - 2025 (USD Million)
Browse full research report on Pyrogen
Testing Market: http://www.grandviewresearch.com/industry-analysis/pyrogen-testing-market
Further
key findings from the report suggest:
- Consumables was the largest revenue grossing
segment of the pyrogen testing market in 2016, owing to the large
application of pyrogen testing kits and reagents along with its repetitive
purchase
- Instruments segment accounted for the
remarkable share in the market in 2016 and is also expected to showcase
significant growth during forecast period, owing to rising demand for
pharmaceutical, biologics, and medical devices for treatment and diagnosis
- The pharmaceutical and biotechnology companies
segment dominated the pyrogen testing market in terms of revenue in 2016,
due to the large production of therapeutic drugs and growing investment in
R&D by companies for drug development
- North America is the leading regional market
and accounted for the largest revenue share in 2016 primarily due to the
existence of large number of healthcare companies including
pharmaceuticals and medical devices in this region
- The Asia Pacific region is anticipated to be
the fastest growing market during the study period. The growing prevalence
rate of chronic diseases in the Asian countries including India and China,
is a major factor contributing to the expansion of market in this region.
- Some major players serving this vertical
include Charles River Laboratories, Inc.; Ellab A/S; Merck KGaA;
GenScript; Hyglos GmbH; Lonza; Thermo Fisher Scientific, Inc.; Associates
of Cape Cod, Inc.; and Pyrostar
Access
Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-pyrogen-testing-market
About
Grand View Research, Inc:
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, the company offers market intelligence
studies ensuring relevant and fact-based research across a range of industries
including technology, chemicals, materials, healthcare and energy.
Comments
Post a Comment